• Discover Exciting Developments in Cell Line Engineering
  •  Best Practices in Bioprocessing Techniques & Antibody Development Strategies
  •   With Both Regional & International Case Studies

‘’Biopharmaceuticals continue to be a growing, important class of pharmaceutical products on the market, and many of these products are produced using mammalian cell culture with total biopharmaceutical sales reaching nearly $130 billion, or approximately 13% of the total pharmaceutical market.’’ – BioProcess Technology

IBC Asia's  4th Annual Cell Line Development and Engineering Conference, provides a platform for industry leaders to overcome the  challenges involved in developing robust cell lines and bringing them to the market successfully.

This event will highlight exciting developments in cell line engineering, explore efficient best practices in bioprocessing techniques,  as well as delve into cutting edge techniques in antibody development, all under-one-roof.

Gain best practice tools and processes which will increase efficiency, productivity and ensure quality in production for companies of all sizes.

Featured Speakers

  • Pengfei Zhou, CEO, Wuhan YZY Biopharma Co Ltd, China
  • Xiang Yang Zhu, CEO at Huaota Biopharm, China
  • Scott Liu, CEO, Henlius Pharmaceuticals, USA
  • Pei Ye Vice, President Beijing Mabworks Biotech, China
  • Peng Wang, President of R&D, Yabao Pharmaceutical Group, China
  • Zhiwei Pan, Senior Director, Cell Culture Process Development, Livzon mAbpharm, China
  • Hao Chen, Ph.D. , Director, Process Development & Engineering, BioProcess R&D, Merck, USA

View all speakers »

Key Conference Themes:

  • New & unpublished data on glycosylation & targeted integration
  • Using omics to improve/direct/engineering the structural quality of specific products
  • Cell culture media development, optimization & feeding strategies
  • Advances in clone screening & selection
  • Development of bispecific antibody therapeutics from cell lines

View full agenda »

细胞株工程及开发研讨会的主要会议主题:

  • 关于糖基化和定点整合的未公布新数据
  • 运用组学技术对特定产品的结构质量进行改进/引导/工程
  • 细胞培养基开发、优化及培育策略
  • 克隆筛选/选择的进展
  • 从细胞株开发双特异抗体疗法

议程 »

About the Biopharma Development & Production Week

The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.  For more information visit www.biopharmaproduction.com

3 Conferences in 1 Location

 

Why You Must Attend in 2015

  • Update yourself with latest technologies to accelerate every stage of cell line development with maximum efficiency, quality and reduced cost
  • Enhance cell line development in the early stages with best practices in transfection, optimizing   cell culture media, and implement advancements in clone screening and selection techniques
  • Gain effective bioprocess control & optimization strategies,  for efficient, safe and cost effective scale up
  • Latest cutting edge updates on antibody development- novel screening strategies for target discovery, challenges in ADCs, engineering bispecifics and boosting efficacy in antibody  therapeutics

Produced bySupporting AssociationSilver SponsorBronze Sponsor

ssociate SponsorSession Spotlight Sponsors  
Exhibitors   
  
Media Partners